INTEGER HOLDINGS CORPORATION Proceeds from Secured Lines of Credit
INTEGER HOLDINGS CORPORATION (ITGR) reported Proceeds from Secured Lines of Credit of $207.60 million for the 6-month period ending 2026-07-03, per its 10-Q filed 2026-08-04.
Financial Statements › Cash Flow › Financing Activities
us-gaap:ProceedsFromSecuredLinesOfCredit · last filed 2026-08-04
- INTEGER HOLDINGS CORPORATION proceeds from secured lines of credit for the quarter ending 2026-07-03 was $95.80M, a 133.66% increase year-over-year.
- INTEGER HOLDINGS CORPORATION proceeds from secured lines of credit for the quarter ending 2026-04-03 was $111.80M, a 48.24% decline year-over-year.
- INTEGER HOLDINGS CORPORATION proceeds from secured lines of credit for the quarter ending 2025-12-31 was $6.00M, a 85.00% decline year-over-year.
- INTEGER HOLDINGS CORPORATION proceeds from secured lines of credit for the quarter ending 2025-09-26 was $44.00M, a 69.23% increase year-over-year.
- INTEGER HOLDINGS CORPORATION proceeds from secured lines of credit for fiscal 2025 was $307.00M, a 11.84% increase from fiscal 2024.
- INTEGER HOLDINGS CORPORATION proceeds from secured lines of credit for fiscal 2024 was $274.50M, a 28.35% decline from fiscal 2023.
- INTEGER HOLDINGS CORPORATION proceeds from secured lines of credit for fiscal 2023 was $383.10M, a 130.78% increase from fiscal 2022.
- INTEGER HOLDINGS CORPORATION proceeds from secured lines of credit for fiscal 2022 was $166.00M, a 101.70% increase from fiscal 2021.
| Period end | Proceeds from Secured Lines of Credit 3 month | Proceeds from Secured Lines of Credit 6 month | Proceeds from Secured Lines of Credit 9 month | Proceeds from Secured Lines of Credit 12 month |
|---|---|---|---|---|
| 2026-07-03 | $95.80M derived: 10-Q 6 month − 10-Q 3 month · filed 2026-08-04 | $207.60M 10-Q · filed 2026-08-04 | $213.60M derived: sum of 3 quarters · filed 2026-08-04 | $257.60M derived: sum of 4 quarters · filed 2026-08-04 |
| 2026-04-03 | $111.80M 10-Q · filed 2026-04-30 | $117.80M derived: sum of 2 quarters · filed 2026-04-30 | $161.80M derived: sum of 3 quarters · filed 2026-04-30 | $202.80M derived: sum of 4 quarters · filed 2026-08-04 |
| 2025-12-31 | $6.00M derived: 10-K 12 month − 10-Q 9 month · filed 2026-02-23 | $50.00M derived: sum of 2 quarters · filed 2026-02-23 | $91.00M derived: sum of 3 quarters · filed 2026-08-04 | $307.00M 10-K · filed 2026-02-23 |
| 2025-09-26 | $44.00M derived: 10-Q 9 month − 10-Q 6 month · filed 2025-10-23 | $85.00M derived: sum of 2 quarters · filed 2026-08-04 | $301.00M 10-Q · filed 2025-10-23 | $341.00M derived: sum of 4 quarters · filed 2026-08-04 |
| 2025-06-27 | $41.00M derived: 10-Q 6 month − 10-Q 3 month · filed 2026-08-04 | $257.00M 10-Q · filed 2026-08-04 | $297.00M derived: sum of 3 quarters · filed 2026-08-04 | $323.00M derived: sum of 4 quarters · filed 2026-08-04 |
| 2025-03-28 | $216.00M 10-Q · filed 2026-04-30 | $256.00M derived: sum of 2 quarters · filed 2026-04-30 | $282.00M derived: sum of 3 quarters · filed 2026-04-30 | $298.50M derived: sum of 4 quarters · filed 2026-04-30 |
| 2024-12-31 | $40.00M derived: 10-K 12 month − 10-Q 9 month · filed 2026-02-23 | $66.00M derived: sum of 2 quarters · filed 2026-02-23 | $82.50M derived: sum of 3 quarters · filed 2026-02-23 | $274.50M 10-K · filed 2026-02-23 |
| 2024-09-27 | $26.00M derived: 10-Q 9 month − 10-Q 6 month · filed 2025-10-23 | $42.50M derived: sum of 2 quarters · filed 2025-10-23 | $234.50M 10-Q · filed 2025-10-23 | $323.00M derived: sum of 4 quarters · filed 2026-02-23 |
| 2024-06-28 | $16.50M derived: 10-Q 6 month − 10-Q 3 month · filed 2025-07-24 | $208.50M 10-Q · filed 2025-07-24 | $297.00M derived: sum of 3 quarters · filed 2026-02-23 | $362.00M derived: sum of 4 quarters · filed 2026-02-23 |
| 2024-03-29 | $192.00M 10-Q · filed 2025-04-24 | $280.50M derived: sum of 2 quarters · filed 2026-02-23 | $345.50M derived: sum of 3 quarters · filed 2026-02-23 | $366.41M derived: sum of 4 quarters · filed 2026-02-23 |
| 2023-12-31 | $88.50M derived: 10-K 12 month − 10-Q 9 month · filed 2026-02-23 | $153.50M derived: sum of 2 quarters · filed 2026-02-23 | $174.41M derived: sum of 3 quarters · filed 2026-02-23 | $383.10M 10-K · filed 2026-02-23 |
| 2023-09-29 | $65.00M derived: 10-Q 9 month − 10-Q 6 month · filed 2024-10-24 | $85.91M derived: sum of 2 quarters · filed 2024-10-24 | $294.60M 10-Q · filed 2024-10-24 | $300.60M derived: sum of 4 quarters · filed 2025-02-20 |
| 2023-06-30 | $20.91M derived: 10-Q 6 month − 10-Q 3 month · filed 2024-07-25 | $229.60M 10-Q · filed 2024-07-25 | $235.60M derived: sum of 3 quarters · filed 2025-02-20 | $235.60M derived: sum of 4 quarters · filed 2025-02-20 |
| 2023-03-31 | $208.69M 10-Q · filed 2024-04-25 | $214.69M derived: sum of 2 quarters · filed 2025-02-20 | $214.69M derived: sum of 3 quarters · filed 2025-02-20 | $359.69M derived: sum of 4 quarters · filed 2025-02-20 |
| 2022-12-31 | $6.00M derived: 10-K 12 month − 10-Q 9 month · filed 2025-02-20 | $6.00M derived: sum of 2 quarters · filed 2025-02-20 | $151.00M derived: sum of 3 quarters · filed 2025-02-20 | $166.00M 10-K · filed 2025-02-20 |
| 2022-09-30 | $0.00 derived: 10-Q 9 month − 10-Q 6 month · filed 2023-10-26 | $145.00M derived: sum of 2 quarters · filed 2023-10-26 | $160.00M 10-Q · filed 2023-10-26 | $160.00M derived: sum of 4 quarters · filed 2024-02-20 |
| 2022-07-01 | $145.00M derived: 10-Q 6 month − 10-Q 3 month · filed 2023-07-27 | $160.00M 10-Q · filed 2023-07-27 | $160.00M derived: sum of 3 quarters · filed 2024-02-20 | $242.30M derived: sum of 4 quarters · filed 2024-02-20 |
| 2022-04-01 | $15.00M 10-Q · filed 2023-04-27 | $15.00M derived: sum of 2 quarters · filed 2024-02-20 | $97.30M derived: sum of 3 quarters · filed 2024-02-20 | $97.30M derived: sum of 4 quarters · filed 2024-02-20 |
| 2021-12-31 | $0.00 derived: 10-K 12 month − 10-Q 9 month · filed 2024-02-20 | $82.30M derived: sum of 2 quarters · filed 2024-02-20 | $82.30M derived: sum of 3 quarters · filed 2024-02-20 | $82.30M 10-K · filed 2024-02-20 |
| 2021-10-01 | $82.30M derived: 10-Q 9 month − 10-Q 6 month · filed 2022-10-27 | $82.30M derived: sum of 2 quarters · filed 2022-10-27 | $82.30M 10-Q · filed 2022-10-27 | $82.30M derived: sum of 4 quarters · filed 2023-02-21 |
| 2021-07-02 | $0.00 derived: 10-Q 6 month − 10-Q 3 month · filed 2022-07-28 | $0.00 10-Q · filed 2022-07-28 | $0.00 derived: sum of 3 quarters · filed 2023-02-21 | $0.00 derived: sum of 4 quarters · filed 2023-02-21 |
| 2021-04-02 | $0.00 10-Q · filed 2022-04-28 | $0.00 derived: sum of 2 quarters · filed 2023-02-21 | $0.00 derived: sum of 3 quarters · filed 2023-02-21 | $160.00M derived: sum of 4 quarters · filed 2023-02-21 |
| 2020-12-31 | $0.00 derived: 10-K 12 month − 10-Q 9 month · filed 2023-02-21 | $0.00 derived: sum of 2 quarters · filed 2023-02-21 | $160.00M derived: sum of 3 quarters · filed 2023-02-21 | $185.00M 10-K · filed 2023-02-21 |
| 2020-10-02 | $0.00 derived: 10-Q 9 month − 10-Q 6 month · filed 2021-10-28 | $160.00M derived: sum of 2 quarters · filed 2021-10-28 | $185.00M 10-Q · filed 2021-10-28 | $199.00M derived: sum of 4 quarters · filed 2022-02-22 |
| 2020-07-03 | $160.00M derived: 10-Q 6 month − 10-Q 3 month · filed 2021-07-29 | $185.00M 10-Q · filed 2021-07-29 | $199.00M derived: sum of 3 quarters · filed 2022-02-22 | $204.00M derived: sum of 4 quarters · filed 2022-02-22 |
| 2020-04-03 | $25.00M 10-Q · filed 2021-04-29 | $39.00M derived: sum of 2 quarters · filed 2022-02-22 | $44.00M derived: sum of 3 quarters · filed 2022-02-22 | $44.00M derived: sum of 4 quarters · filed 2022-02-22 |
| 2019-12-31 | $14.00M derived: 10-K 12 month − 10-Q 9 month · filed 2022-02-22 | $19.00M derived: sum of 2 quarters · filed 2022-02-22 | $19.00M derived: sum of 3 quarters · filed 2022-02-22 | $34.00M 10-K · filed 2022-02-22 |
| 2019-09-27 | $5.00M derived: 10-Q 9 month − 10-Q 6 month · filed 2020-10-29 | $5.00M derived: sum of 2 quarters · filed 2020-10-29 | $20.00M 10-Q · filed 2020-10-29 | |
| 2019-06-28 | $0.00 derived: 10-Q 6 month − 10-Q 3 month · filed 2020-07-30 | $15.00M 10-Q · filed 2020-07-30 | ||
| 2019-03-29 | $15.00M 10-Q · filed 2020-05-08 | |||
| 2018-09-28 | $0.00 10-Q · filed 2019-10-31 |
Similar stocks
| Stock Name | Country | Market Cap | PE Ratio |
|---|---|---|---|
| LivaNova PLC (LIVN) | $4.158B | 24.01 | |
| TransMedics Group, Inc. (TMDX) | United States | $2.911B | 15.17 |
| Axogen, Inc. (AXGN) | United States | $2.329B | -73.83 |
| BIOLIFE SOLUTIONS INC (BLFS) | United States | $1.887B | 23.80 |
| CONMED Corp (CNMD) | United States | $1.353B | 26.72 |
| Ceribell, Inc. (CBLL) | United States | $0.916B | -11.27 |
| CapsoVision, Inc (CV) | United States | $0.310B | -12.68 |
| Electromed, Inc. (ELMD) | United States | $0.233B | 31.13 |
| EDAP TMS SA (FOCL) | $0.171B | ||
| Stereotaxis, Inc. (STXS) | United States | $0.130B | -7.53 |